Inventor · disambiguated record
Steven A. Goldman
Also filed as: GOLDMAN STEVEN · GOLDMAN STEVEN A
46 granted patents·41 pending applications·466 citations·filing 1978–2024
98Inventor score
Files withUNIV ROCHESTER34CORNELL RES FOUNDATION INC16GOLDMAN STEVEN A10UNIV ARIZONA9AVERY THERAPEUTICS INC4
Top patents by PatentIndex Score
87 records- 0197US10279051B2Non-human mammal model of human degenerative disorder, uses thereof, and method of treating human degenerative disorderUNIV ROCHESTER·Filed 2017·Granted May 7, 2019·10 cites·8 claims
- 0295US9724432B2Non-human mammal model of human degenerative disorder, uses thereof, and method of treating human degenerative disorderGOLDMAN STEVEN A·Filed 2015·Granted Aug 8, 2017·9 cites·27 claims
- 0394US10626369B2Induced pluripotent cell-derived oligodendrocyte progenitor cells for the treatment of myelin disordersUNIV ROCHESTER·Filed 2017·Granted Apr 21, 2020·8 cites·7 claims
- 0492US11596700B2Non-human mammal model of human degenerative disorder, uses thereof, and method of treating human degenerative disorderUNIV ROCHESTER·Filed 2017·Granted Mar 7, 2023·3 cites·23 claims
- 0592US10450546B2Induced pluripotent cell-derived oligodendrocyte progenitor cells for the treatment of myelin disordersUNIV ROCHESTER·Filed 2014·Granted Oct 22, 2019·14 cites·9 claims
- 0692US8206699B2Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cellsGOLDMAN STEVEN A·Filed 2008·Granted Jun 26, 2012·26 cites·12 claims
- 0792US7524491B2Non human animals with human-glial chimeric brainsUNIV ROCHESTER·Filed 2008·Granted Apr 28, 2009·23 cites·50 claims
- 0891US11344582B2Treating myelin diseases with optimized cell preparationsUNIV ROCHESTER·Filed 2017·Granted May 31, 2022·6 cites·21 claims
- 0991US10190095B2Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cellsCORNELL RES FOUNDATION INC·Filed 2016·Granted Jan 29, 2019·9 cites·9 claims
- 1090US10779519B2Human glial chimeric model for drug candidate assessment in human gliotrophic viral infections and progressive multifocal encephalopathyUNIV ROCHESTER·Filed 2015·Granted Sep 22, 2020·5 cites·13 claims
- 1189US11690876B2Methods of treating neuropsychiatric disordersUNIV ROCHESTER·Filed 2018·Granted Jul 4, 2023·3 cites·8 claims
- 1289US9709553B2Treating myelin diseases with optimized cell preparationsGOLDMAN STEVEN·Filed 2009·Granted Jul 18, 2017·24 cites·12 claims
- 1389US7150989B2Telomerase immortalized neural progenitor cellsCORNELL RES FOUNDATION INC·Filed 2002·Granted Dec 19, 2006·27 cites·45 claims
- 1489US2025019653A1Induced pluripotent cell-derived oligodendrocyte progenitor cells for the treatment of myelin disordersUNIV ROCHESTER·Filed 2024·Application pending·0 cites
- 1588US9371513B2Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cellsGOLDMAN STEVEN A·Filed 2012·Granted Jun 21, 2016·11 cites·15 claims
- 1687US6692957B2Method for separating cellsCORNELL RES FOUNDATION INC·Filed 2001·Granted Feb 17, 2004·20 cites·28 claims
- 1785US7803752B2Method of inducing neuronal production in the caudate nucleus and putamenCORNELL RES FOUNDATION INC·Filed 2006·Granted Sep 28, 2010·4 cites·17 claims
- 1883US8399518B2Administration of 3,5-diiodothyropropionic acid for stimulating weight loss, and/or lowering triglyceride levels, and/or treatment of metabolic syndromeMORKIN EUGENE·Filed 2008·Granted Mar 19, 2013·6 cites·26 claims
- 1982US6245564B1Method for separating cellsCORNELL RES FOUNDATION INC·Filed 1997·Granted Jun 12, 2001·69 cites·14 claims
- 2082US2023173110A1Non-human mammal model of human degenerative disorder, uses thereof, and method of treating human degenerative disorderUNIV ROCHESTER·Filed 2023·Application pending·0 cites
- 2181US12305195B2Induced pluripotent cell-derived oligodendrocyte progenitor cells for the treatment of myelin disordersUNIV ROCHESTER·Filed 2022·Granted May 20, 2025·0 cites·8 claims
- 2281US6534676B2Method to treat chronic heart failure and/or elevated cholesterol levels using 3,5-diiodothyropropionic acid and method to prepare sameUNIV ARIZONA·Filed 2001·Granted Mar 18, 2003·31 cites·20 claims
- 2380US7468277B2Enriched preparation of human fetal multipotential neural stem cellsCORNELL RES FOUNDATION INC·Filed 2000·Granted Dec 23, 2008·6 cites·8 claims
- 2480US6812027B2Discovery, localization, harvest, and propagation of an FGF2 and BDNF-responsive population of neural and neuronal progenitor cells in the adult human forebrainCORNELL RES FOUNDATION INC·Filed 1999·Granted Nov 2, 2004·40 cites·25 claims
- 2578US12178834B2Treating myelin diseases with optimized cell preparationsUNIV ROCHESTER·Filed 2022·Granted Dec 31, 2024·0 cites·24 claims
- 2678US7807145B2Method of inducing neuronal production in the brain and spinal cordCORNELL RES FOUNDATION INC·Filed 2006·Granted Oct 5, 2010·1 cites·14 claims
- 2776US12129484B2Induced pluripotent cell-derived oligodendrocyte progenitor cells for the treatment of myelin disordersUNIV ROCHESTER·Filed 2019·Granted Oct 29, 2024·0 cites·20 claims
- 2876US8642332B2Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brainGOLDMAN STEVEN A·Filed 2004·Granted Feb 4, 2014·5 cites·5 claims
- 2976US7923448B2Purine receptor inhibition as a therapeutic strategy in spinal cord and brainCORNELL RES FOUNDATION INC·Filed 2004·Granted Apr 12, 2011·6 cites·26 claims
- 3074US11980698B2Muscle cell patches and uses thereforUNIV ARIZONA·Filed 2021·Granted May 14, 2024·0 cites·4 claims
- 3174US10485807B2Modulating the production of neurons and/or oligodendrocytes from white matter progenitor cellsCORNELL RES FOUNDATION INC·Filed 2016·Granted Nov 26, 2019·1 cites·6 claims
- 3273US8945921B2Modulating the production of neurons and/or oligodendrocytes from white matter progenitor cellsGOLDMAN STEVEN A·Filed 2009·Granted Feb 3, 2015·1 cites·5 claims
- 3373US2023241118A1Rejuvenation treatment of age-related white matter lossUNIV ROCHESTER·Filed 2022·Application pending·0 cites
- 3473US2023277600A1Treatment Of Age-Related White Matter Loss By Competitive Replacement Of Glial CellsUNIV ROCHESTER·Filed 2022·Application pending·0 cites
- 3573US2023159890A1Treatment with genetically modified cells, and genetically modified cells per se, with increased competitive advantage and/or decreased competitive disadvantageUNIV ROCHESTER·Filed 2022·Application pending·0 cites
- 3672US2023293594A1Methods of treating neuropsychiatric disordersUNIV ROCHESTER·Filed 2023·Application pending·0 cites
- 3771US7037493B2Method of inducing neuronal production in the brain and spinal cordCORNELL RES FOUNDATION INC·Filed 2001·Granted May 2, 2006·3 cites·10 claims
- 3871US2023226116A1Method for rejuvenating glial progenitor cells and rejuvenated glial progenitor cells per seUNIV ROCHESTER·Filed 2022·Application pending·0 cites
- 3970US11020510B2Muscle cell patches and uses thereforUNIV ARIZONA·Filed 2018·Granted Jun 1, 2021·0 cites·18 claims
- 4070US7785882B2Neuronal progenitor cells from hippocampal tissue and a method for isolating and purifying themCORNELL RES FOUNDATION INC·Filed 2001·Granted Aug 31, 2010·1 cites·6 claims
- 4169US2024167034A1Methods and compositions for rejuvenating cns glial populations by suppresion of transcription factorsUNIV ROCHESTER·Filed 2023·Application pending·0 cites
- 4268US8263402B1Method for isolating and purifying oligodendrocytes and oligodendrocyte progenitor cellsGOLDMAN STEVEN A·Filed 1999·Granted Sep 11, 2012·23 cites·18 claims
- 4368US8263406B2Enriched or purified population of motor neurons and its preparation from a population of embryonic stem cellsGOLDMAN STEVEN A·Filed 2004·Granted Sep 11, 2012·1 cites·18 claims
- 4467US7576065B2Enhancing neurotrophin-induced neurogenesis by endogenous neural progenitor cells by concurrent overexpression of brain derived neurotrophic factor and an inhibitor of a pro-gliogenic bone morphogenetic proteinCORNELL RES FOUNDATION INC·Filed 2003·Granted Aug 18, 2009·2 cites·26 claims
- 4567US2024165269A1Methods and compositions for rejuvenating cns glial populations with bcl11a transcription factor expressionUNIV ROCHESTER·Filed 2023·Application pending·0 cites
- 4666US12303549B2Methods of treating or inhibiting onset of Huntington's diseaseUNIV ROCHESTER·Filed 2019·Granted May 20, 2025·1 cites·19 claims
- 4766US2025073354A1Compositions and methods for delivery of agents to inner earUNIV ROCHESTER·Filed 2022·Application pending·0 cites
- 4864US2025161495A1Methods of generating a population of neurons from human glial progenitor cells and genetic constructs for carrying out such methodsUNIV ROCHESTER·Filed 2023·Application pending·0 cites
- 4964US2025082777A1Methods of ex vivo dosing and administration of lipid particles or viral vectors and related systems and usesSANA BIOTECHNOLOGY INC·Filed 2023·Application pending·0 cites
- 5063US2025276020A1Dual macroglial-microglial approach towards therapeutic cell replacement in neurodegenerative and neuropsychiatric diseaseUNIV ROCHESTER·Filed 2023·Application pending·0 cites
Showing the top 50 of 87 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Steven A. Goldman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →